Details for New Drug Application (NDA): 017369
✉ Email this page to a colleague
NDA 017369 describes TELDRIN, which is a drug marketed by Glaxosmithkline and is included in one NDA. Additional details are available on the TELDRIN profile page.
The generic ingredient in TELDRIN is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.
The generic ingredient in TELDRIN is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.
Summary for 017369
| Tradename: | TELDRIN |
| Applicant: | Glaxosmithkline |
| Ingredient: | chlorpheniramine maleate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017369
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 8MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 12MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
